The use of TDM in pregnant HIV-positive women: a retrospective cross-sectional review of five years practice in two large hospitals in Manchester

INTRODUCTION: Despite plasma levels of certain HIV drugs decreasing in the third trimester of pregnancy there is no definitive evidence that therapeutic drug monitoring (TDM) improves HIV control and prevents mother-to-child transmission (MTCT). Indeed “one-off” TDM measurements are thought to poorl...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitfield, Thomas, Dessain, Amabel, Taylor, Kelly, McQuillan, Orla, Looi, Evelyn, Kingston, Margaret, Ajdukiewicz, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P163
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225314/
https://www.ncbi.nlm.nih.gov/pubmed/25397445
http://dx.doi.org/10.7448/IAS.17.4.19695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225314/
https://www.ncbi.nlm.nih.gov/pubmed/25397445
http://dx.doi.org/10.7448/IAS.17.4.19695

Ejemplares similares